EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional Evaluation of Computationally Designed IL-10 in IL-10 KO Mice

Jordan Stokes, Iram Hyder, Zhihang Shen iD, Peter Ramdhan iD, Allison Bayer, Clive Wasserfall, Chenglong Li, Sihong Song iD

Biomolecules · 23.03.2026 · 16 (3) · 482

DOI: 10.3390/biom16030482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 23.03.2026. Verfasst von Jordan Stokes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Interleukin-10, Inflammatory Bowel Diseases. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, DOD.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Studies have shown that IL-10 has therapeutic potential for inflammatory diseases. However, it is challenging to use IL-10 as a therapeutic drug because it also possesses pro-inflammatory functions. To reduce these pro-inflammatory effects of IL-10, we have designed three IL-10 mutants using structure-based computational design technology. We demonstrated that these mutants exhibited significantly lower activity in IL-10-responsive cell lines than wild-type IL-10. Using recombinant adeno-associated virus (rAAV8) vectors expressing wild-type or mutant IL-10 molecules, we performed gene therapy experiments in IL-10 KO mice. The results showed that our vectors mediated high levels of transgene expression. Importantly, IL-10 gene therapy increased body weight gain, reduced colon injury, and prevented the development of inflammatory bowel disease (IBD). Moreover, IL-10 mutant gene therapy elicited significantly lower stimulation of CD8 T and NK cells compared with the wild-type IL-10 group. In summary, our IL-10 mutants provide a protective effect comparable to wild-type IL-10 in the IL-10 KO mouse model, suggesting that they may potentially have reduced pro-inflammatory function. While rigorous investigations of safety and efficacy in different disease models will be required, these results indicate the therapeutic potential of IL-10 mutant gene therapy for inflammatory diseases such as IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Inflammatory Bowel DiseasesAnimalsMiceMice, KnockoutGenetic TherapyDependovirusGenetic VectorsGene Therapy AgentsHumans

Stichwörter der Autor:innen

Interleukin 10 (IL-10)computational design of a protein drug and gene therapyinflammatory bowel diseaserecombinant adeno-associated virus vector

Substanzen

Interleukin-10IL10 protein, mouse

Autor:innen und Institutionen

  • Departments of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL 32610, USA.
  • Department of Medicinal Chemistry, University of Florida College of Pharmacy, Gainesville, FL 32610, USA.
  • Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA.

ORCID-Profile: Zhihang Shen, Peter Ramdhan, Sihong Song

Förderung

  • United States Department of Defense
  • DOD

Zitieren

APA

Stokes, J., Hyder, I., Shen, Z., Ramdhan, P., Bayer, A., Wasserfall, C., Li, C., & Song, S. (2026). Functional Evaluation of Computationally Designed IL-10 in IL-10 KO Mice. Biomolecules, 16(3), 482. https://doi.org/10.3390/biom16030482

Vancouver

Stokes J, Hyder I, Shen Z, Ramdhan P, Bayer A, Wasserfall C, et al. Functional Evaluation of Computationally Designed IL-10 in IL-10 KO Mice. Biomolecules. 2026;16(3):482. doi:10.3390/biom16030482

BibTeX
@article{Stokes2026,
  author = {Stokes, Jordan and Hyder, Iram and Shen, Zhihang and Ramdhan, Peter and Bayer, Allison and Wasserfall, Clive and Li, Chenglong and Song, Sihong},
  title = {Functional Evaluation of Computationally Designed IL-10 in IL-10 KO Mice},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {482},
  doi = {10.3390/biom16030482}
}
Kostenlos starten →